|1.||O'Rourke, Donald M: 1 article (01/2003)|
|2.||Maity, Amit: 1 article (01/2003)|
|3.||Liu, Shuang: 1 article (01/2003)|
|4.||Haas-Kogan, Daphne A: 1 article (01/2003)|
|5.||Pore, Nabendu: 1 article (01/2003)|
|6.||Solomon, D: 1 article (10/2000)|
|7.||Lee, J: 1 article (10/2000)|
|8.||Pore, N: 1 article (10/2000)|
|9.||O'Rourke, D M: 1 article (10/2000)|
|10.||Maity, A: 1 article (10/2000)|
|1.||Glioblastoma (Glioblastoma Multiforme)
01/01/2003 - "Several glioblastoma cell lines containing mutant PTEN, including U87MG, U87/T691, and U251MG, were infected with adenovirus expressing wild-type PTEN. "
10/15/2000 - "We examined VEGF regulation in U87 MG human glioblastoma cells and in U87/T691 cells, a clonal derivative that contains a truncated erbB2/Neu receptor that interferes with EGFR signaling through the formation of nonfunctional heterodimeric receptor complexes. "
01/01/2003 - "Our previous work showed that, compared with parental U87MG human glioblastoma cells, vascular endothelial growth factor (VEGF) mRNA levels are decreased in U87/T691, a derivative line in which epidermal growth factor receptor (EGFR) signaling is inhibited by introduction of a truncated p185(Neu) protein (A. "
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|2.||Messenger RNA (mRNA)
|3.||erbB-2 Receptor (Receptor, erbB 2)
|4.||Staphylococcal Protein A (A, Protein)
|5.||Epidermal Growth Factor Receptor (EGF Receptor)